2
S.-C. So et al. / Journal of Organometallic Chemistry 853 (2017) 1e4
solution in THF, 1.6 mmol) at 0 ꢀC. The resulting orange mixture was
stirred for 15 min at 0 ꢀC and the volatiles were removed in vacuo.
Methanol was added and the resulting suspension was cooled to
0
ꢀC. The yellow precipitate was collected by vacuum filtration,
washed with two portions of cold methanol (10 mL), and dried
under high vacuum. Recrystallization from CH2Cl2/hexanes affor-
ded orange crystals which were suitable for X-ray diffraction
analysis. Yield: 1.1 g, 80%. 1H NMR (400 MHz, C6D6):
d
¼ 0.17 (s, 9H,
CH3), 2.72 (s, 6H, CH3), 5.93 (s, 2H, Ph), 7.10 (m, 18H, Ph), 7.82 (m,
12H, Ph) ppm. 31P {1H} NMR (CDCl3):
¼ 19.50 (s) ppm. Anal. Calcd
for C47H47BrNiOP2Si: C, 55.88; H, 4.69. Found: C, 55.73; H, 4.73.
Scheme 1. Examples of heteroatom-substituted quinoidal compounds [2e4].
d
2.5. Synthesis of [Ni(PPh3)(C6H2Me2-2,6-OH-4)]2(
mꢁOH)2 (4)
To a solution of 3 (100 mg, 0.12 mmol) in THF (10 mL) was added
1.5 equivalents of nBu4NF,H2O (0.18 mL of a 1 M solution in THF,
0.18 mmol) at ꢁ78 ꢀC. The resulting mixture was then warmed to
room temperature and stirred overnight. The volatiles were
removed in vacuo. The residue was washed with hexanes and then
extracted with MeCN. Recrystallization from MeCN/Et2O afforded
yellow crystals which were suitable for X-ray diffraction. Yield:
Scheme 2. A PCP pincer-based ruthenaquionone [5].
33 mg, 52%. 1H NMR (400 MHz, CD3CN):
(s, 6H, CH3), 5.85 (br, 2H, OH), 5.92 (s, 4H, Ph), 7.24e7.37 (m, 30H,
Ph) ppm. 31P {1H} NMR (CDCl3):
¼ 21.20 (s) ppm. Anal. Calcd for
52H50Ni2O4P2: C, 68.01; H, 5.49. Found: C, 68.16; H, 5.28 .
d
¼ ꢁ4.0 (br, 2H, OH), 2.98
[9]) and [Ni(PPh3)2Cl2] [10] were prepared according to literature
methods. 2,6-Dimethyl-4-trimethylsiloxyphenylmagnesium bro-
mide was prepared by treatment of 1-bromo-2,6-dimethyl-4-
trimethylsiloxybenzene, which was obtained from 4-bromo-3,5-
dimethylphenol and chorotrimethylsilane, with Mg in tetrahydro-
furan (THF).
d
C
2.6. X-ray crystallography
Crystal data and experimental details for 1, 3, and 4 are sum-
marized in Table 1. Preliminary examinations and intensity data
collection were carried out on a Bruker SMART APEX 1000 CCD
diffractometer. The collected frames were processed with the
software SAINT. The data was corrected for absorption using the
program SADABS [11]. Structures were solved by direct methods
and refined by full-matrix least-squares on F2 using the SHELXTL
software package [12]. Unless stated otherwise, non-hydrogen
atoms were refined with anisotropic displacement parameters.
Carbon-bonded hydrogen atoms were included in calculated po-
sitions and refined in the riding mode using SHELXL97 default
parameters. CCDC 1539784, 1540324 and 1540325 contains the
supplementary crystallography data for 1, 3, and 4, respectively.
2.2. Reaction of [Pd(PPh3)4] with 4-bromo-2,6-di-tert-butylphenol
To a suspension of [Pd(PPh3)4] (230 mg, 0.2 mmol) in toluene
(10 mL) was added 1 equivalent of 4-bromo-2,6-di-tert-butylphe-
nol (57 mg, 0.2 mmol). The resulting solution was refluxed for 2 d,
and the volatiles were removed in vacuo. The residue was washed
with hexanes and then extracted with CH2Cl2. Recrystallization
from CH2Cl2/hexanes afforded yellow crystals that were charac-
terized as the phosphaquinone Ph3P ¼ C6Ht3Bu2-3,5-O-4 (1) by X-
ray crystallography. Yield: 50 mg, 54%. 1H NMR (400 MHz, CDCl3):
d
¼ 1.31 (s, 18H, CH3), 6.84 (s, 2H, Ph), 7.60e7.72 (m, 15H, Ph) ppm.
13C {1H} NMR (100 MHz, CDCl3):
¼ 28.82 (s), 34.63 (s), 122.11 (s),
122.99 (s), 140.15 (s), 176.21 (s) ppm. 31P {1H} NMR (CDCl3):
d
d
¼ 20.74 (s) ppm. Anal. Calcd for C32H35OP: C, 82.37; H, 7.56.
Table 1
Found: C, 81.50; H, 7.24.
Crystallographic data and experimental details for 1, 3 and 4.
2.3. Reaction of [M(PPh3)4] (M ¼ Ni, Pt) with 4-bromo-2,6-di-tert-
1$0.125(C4H8O)
3$CH2Cl2
4$2CH3CN
butylphenol
Formula
Fw
C32H35OP
475.58
10.8259(2)
18.4075(3)
14.8443(2)
90
94.853(2)
90
2947.53(8)
4
monoclinic
1.072
P21/n
173.15
0.973
C47H47BrNiOP2Si
941.42
C52H50Ni2O4P2
1000.39
14.01551(11)
12.82811(10)
27.58082(19)
90
97.8616(7)
90
4912.22(6)
4
monoclinic
1.353
P21/n
100.0(2)
1.947
2096
A mixture of [Ni(PPh3)4] or [Pt(PPh3)4] (0.2 mmol) and 4-bromo-
2,6-di-tert-butylphenol (0.2 mol) in toluene (10 mL) was heated at
reflux for 2 d, and the volatiles were removed in vacuo. The residue
was washed with hexanes and then extracted with CH2Cl2.
Recrystallization from CH2Cl2/Et2O/hexanes afforded yellow crys-
tals that were identified as the biquione [C6Ht3Bu2-3,5-O-4]2 (2) by
X-ray crystallography. Yield: 40%. 1H NMR (400 MHz, CDCl3):
a [Å]
b [Å]
c [Å]
11.7312(4)
12.2073(5)
17.6080(5)
95.260(3)
93.322(3)
116.250(4)
2238.28(14)
2
triclinic
1.397
P-1
99.98(6)
3.969
a
b
g
[o]
[o]
[o]
V [Å3]
Z
Cryst system
rcalcd [g$cmꢁ1
Space group
T [K]
d
¼ 1.35 (s, 36H, CH3), 7.70 (s, 4H, Ph) ppm. 13C {1H} NMR (100 MHz,
]
CDCl3):
d
¼ 28.95 (s), 35.38 (s), 125.38 (s), 135.49 (s), 149.78 (s),
185.92 (s) ppm. Anal. Calcd for C28H40O2: C,82.30; H, 9.87. Found: C,
81.79; H, 10.04.
m
[mmꢁ1
F(000)
No. of reflns
]
1020
8830
4910
972
12411
7872
19228
8757
2.4. Synthesis of cis-[Ni(PPh3)2Br(C6H2Me2-2,6-OSiMe3-4)] (3)
No. of indep reflns
R(int)
0.0626
0.0290
0.0201
R1, wR2 (I > 2
R1, wR2 (all data)
GoF
s
(I))
0.0598, 0.1355
0.0971, 0.1560
1.002
0.0446, 0.1205
0.0555, 0.1264
1.002
0.0268, 0.0657
0.0337, 0.06823
1.002
To a solution of [NiCl2(PPh3)2] (1 g, 1.60 mmol) in THF (10 mL)
was
added
1
equivalent
of
2,6-dimethyl-4-
trimethylsiloxyphenylmagnesium bromide (3.2 mL of 0.5
M